panobinostat

Priority review period for Novartis cancer drug extended
Seeking Alpha
Tue, 11/25/14 - 09:57 am
Novartis
Multiple Myeloma
panobinostat
bortezomib
The FDA's Oncologic Drugs Advisory Committee Will Likely Vote Against Novartis' Panobinostat
Seeking Alpha
Thu, 11/6/14 - 09:47 am
FDA
advisory panels
Novartis
panobinostat
Multiple Myeloma
Novartis: 2 Novel Cancer Therapies Show Promising Results
Seeking Alpha
Wed, 12/11/13 - 02:42 pm
Novartis
Celgene
JNJ
Merck
panobinostat
Multiple Myeloma
acute lymphocytic leukemia